| MACULOPATHIE ET AUTRES ANOMALIES | |||||||||
| NON ANALYSABLE | NORMAL | OEDEME | MLA | AUTRE MACULOPATHIE | AUTRE RETINOPATHIE | TOTAL | |||
| OD | 13 | 36 | 0 | 6 | 1 | 1 | 57 | ||
| OG | 13 | 37 | 0 | 5 | 1 | 1 | 57 | ||
| OD + OG | 26 | 73 | 0 | 11 | 2 | 2 | 114 | ||
| N/A | NORMAL | OEDEME | MLA | AUTRE MACULOPATHIE | AUTRE RETINOPATHIE | ||||
| OD | 22,81% | 63,16% | 0,00% | 10,53% | 1,75% | 1,75% | 100,00% | ||
| OG | 22,81% | 64,91% | 0,00% | 8,77% | 1,75% | 1,75% | 100,00% | ||
| MOYENNE | 22,81% | 64,04% | 0,00% | 9,65% | 1,75% | 1,75% | 100,00% | ||
| NON ANALYSABLE | NORMAL | OEDEME | MLA | AUTRE MACULOPATHIE | AUTRE RETINOPATHIE | TOTAL | |||
| HOMMES | 3 | 23 | 0 | 4 | 2 | 2 | 34 | ||
| 8,82% | 67,65% | 0,00% | 11,76% | 5,88% | 5,88% | 100,00% | |||
| FEMMES | 4 | 17 | 0 | 2 | 0 | 0 | 23 | ||
| 17,39% | 73,91% | 0,00% | 8,70% | 0,00% | 0,00% | 100,00% | |||
| TOTAL | 7 | 40 | 0 | 6 | 2 | 2 | 57 | ||
| 12,28% | 70,18% | 0,00% | 10,53% | 3,51% | 3,51% | 100,00% | |||
|
|
|||||||||
|
|
|||||||||